ライフサイエンスコーパス: nude

1 Nude and GKO mice fulfilled criteria for the model but o

2 1/2 inhibitors in reversing vasoocclusion in nude and humanized SCD mouse models of acute vasoocclusi

3 We also observe that T-cell-deficient (nude and Rag1-null mutant) pregnant mice do not exhibit

4 nsplanted BVE-PTC tumors subcutaneously into nude and TPO-Braf(WT) mice.

5 the transplanted tumors was observed in both nude and TPO-Braf(WT) mice.

6 of male and female mice (129S6/SvEv, athymic nude, and BALB/c).

7 Yet how the activities of Lis1, Nudel/NudE, and dynactin are coordinated to regulate dynein re

8 d time-dependent tumor uptake was studied in nude BALB/c mice bearing a subcutaneous HER3 overexpress

9 p to 6 d after intravenous administration to nude BALB/c mice bearing high EpCAM-expressing HT-29 col

10 umor growth was significantly decreased when nude BALB/c mice were injected with Msi1-knockdown BCCs.

11 ains were evaluated: Swiss, BALB/c, C57BL/6, nude, beige, A/J, and GKO.

12 n or down-regulation of the dynein cofactors NudE/EL.

13 in Xenopus egg extracts, we show that Nudel/NudE facilitates the binding of Lis1 to dynein, which en

14 was performed in tumour xenografts in 15 NCr nude immunodeficient mice, which were treated with eithe

15 r the cytoplasmic dynein regulators LIS1 and NudE/L (Nde1/Ndel1), but not for the dynactin p150(Glued

16 tein and subcutaneously injected into BALB/c nude male mice.

17 scles were subcutaneously injected into CD-1 nude mice (CD-1 nude mice, Crl:CD1-Foxn1(nu); Charles Ri

18 lls (HT-29) were grafted subcutaneously into nude mice (n = 111).

19 cells from the rectus abdominis muscle into nude mice (n = 18).

20 Human NK cells injected in CD1 nude mice accumulated in the ARO tumors within 24 h and

21 Irradiation of s.c. HT-1080 tumors in nude mice administered i.v. docetaxel-containing nanopar

22 cells, and in both eight-patient bloods and nude mice administered with the labeled CTCs in comparis

23 K1/2 inhibitor given to TNF-alpha-pretreated nude mice after human SSRBC infusion and onset of vasooc

24 experiments were performed on tumor-bearing nude mice after subcutaneous injection of RIN-m5F cells.

25 Xenografts in nude mice and bone metastasis models confirmed the remar

26 tifying the biodistribution of antibodies in nude mice and provides an alternative to PET analysis in

27 Breast cancers were established in nude mice and treated with intratumoral injections of ad

28 ChA-1 cells were injected into the flanks of nude mice and treated with miR-24 inhibitor or inhibitor

29 ly than Dox-MPEG-PCL and HK-MPEG-PCL in both nude mice and zebrafish tumor models.

30 Nude mice are an adequate model for in vivo chemotherapy

31 Nude mice are important in vivo model for characterizati

32 In vivo experiments, using nude mice as the model organism, demonstrated a strong b

33 he miR-378-expressing cells formed tumors in nude mice at low cell densities.

34 Athymic nude mice bearing (V600E)BRAF-expressing human CRC cell

35 We treated groups of nude mice bearing 7-d-old SW1222 xenografts with a fract

36 al PET experiments were performed in athymic nude mice bearing a BON-1 tumor xenograft.

37 FHNP and (18)F-FES were conducted in athymic nude mice bearing a SKOV3 xenografts.

38 these two dual-labeled conjugates in female nude mice bearing A2780 human ovarian carcinoma.

39 dent SSM3 mouse mammary tumors, male athymic nude mice bearing androgen-dependent CWR22 prostate canc

40 trigel suspension model was established with nude mice bearing cells equally infected with each repor

41 get NCI-H358-HER2 CRISPR knock out tumors in nude mice bearing dual-flank tumor xenografts.

42 ncer xenografts, and male and female athymic nude mice bearing estrogen-independent MDA-MB-231 human

43 jected intravenously into the BALB/c athymic nude mice bearing folate receptor (FR)-overexpressing KB

44 nd biodistribution studies were performed in nude mice bearing HCC4006 and A549 xenograft tumors.

45 ance the anti-tumor activity of Sorafenib in nude mice bearing HepG2 xenografts.

46 icacy of PEG-GIRLRG peptide was evaluated in nude mice bearing heterotopic cervical (HT3), esophageal

47 ce, and tumor targeting was assessed in CD-1 nude mice bearing high-HER2-expressing NCI-N87 tumors an

48 antitumor efficacy over single treatment on nude mice bearing HT-29 colon cancer xenograft.

49 f biodistribution and PET imaging studies on nude mice bearing INR1G9-hGIPr tumors.

50 rubicin rapidly eradicated tumors in athymic nude mice bearing KB or MIA Paca-2 xenografts.

51 In vivo antitumor efficacy was tested in nude mice bearing PSMA+ PC3 PIP or PSMA- PC3 flu flank x

52 tion and SPECT/CT imaging experiments, using nude mice bearing PSMA-positive PC-310 and PSMA-negative

53 macokinetics and PET imaging were studied in nude mice bearing rat Ins-1E tumors.

54 distribution experiments were performed with nude mice bearing RIN-m5F xenografts.

55 Nude mice bearing SQ20b xenograft tumors were administer

56 ected intravenously into separate cohorts of nude mice bearing subcutaneous A-431 tumors.

57 of tumor cure while being well tolerated by nude mice bearing subcutaneous GPA33-positive SW1222 xen

58 One-hour dynamic PET scans were performed on nude mice bearing subcutaneous human head and neck tumor

59 cs of (89)Zr-DFO-AC-10 was studied in BALB/c nude mice bearing subcutaneous human Karpas 299 tumors (

60 nd biodistribution studies were performed on nude mice bearing U87MG and MDA-MB-231 xenografted tumor

61 ntiation of single agent activity in vivo in nude mice bearing xenografts.

62 /kg MEK1/2 inhibitor to TNF-alpha-pretreated nude mice before human SSRBC infusion inhibited SSRBC ad

63 o-CT was performed on HCC model implanted in nude mice by intrahepatic injection.

64 n HCC827, H1975, H358 and H520 tumor-bearing nude mice by PET/CT imaging.

65 117085 significantly reduces tumor growth in nude mice compared with control untreated mice or either

66 Xenograft studies in NUDE mice demonstrated stable SOX2 repression and long-t

67 In vivo experiments with Swiss nude mice demonstrated that cancer cells expressing the

68 Adoptive transfer of T cells into nude mice demonstrated that CD8(+) T cells were responsi

69 Experiments using nude mice demonstrated that the ectopic EPSTI1 granted t

70 Importantly, nude mice developed anti-nuclear Abs when transplanted w

71 vivo an orthotopic liver injection model in nude mice further demonstrated that knockdown of RhoE en

72 ntal pulp on poly-l-lactic acid scaffolds in nude mice gave rise to perfect heterotopic ossicles in v

73 ication involving the TKD into the brains of nude mice generated high-grade astrocytomas with short l

74 Treatment of nude mice harboring established tumors made of a mix of

75 Nude mice implanted s.c. with TROP-2-expressing PC3 huma

76 ild cardiac hypertrophy was also observed in nude mice implanted with IDH2(R140Q)-expressing xenograf

77 growth of human colon carcinoma xenograft in nude mice in an RXRalpha-dependent manner.

78 in autoreactivity after transplantation into nude mice in vivo.

79 ties, SPECT and CT scans of HT29-xenografted nude mice injected with (177)Lu-3BP-227 were acquired, a

80 tically attenuates tumor growth in xenograft nude mice injected with human K562 leukemia cells and ce

81 Subcutaneous injection of TRIM24 iHMECs in nude mice led to growth of intermediate to high-grade tu

82 id gland scaffolds into the renal capsule of nude mice led to the differentiation of transplanted hDF

83 e rate of tumor progression in a xenografted nude mice model.

84 potent anti-hepatoma activity in a xenograft nude mice model.

85 In nude mice models, combination of all-trans retinoic acid

86 angiogenesis in chorioallantoic membrane and nude mice models.

87 apoptosis of human BACs in cell culture and nude mice models.

88 but not bortezomib suppresses the growth in nude mice of human breast tumor xenografts.

89 ce fulfilled criteria for the model but only nude mice offered sufficient availability for large ther

90 0A silencing precluded liver colonization in nude mice or metastasis.

91 ve transfer of congenic T cells into athymic nude mice prior to infection did not alter lesion size.

92 implantation of LOX-treated neocartilage in nude mice promoted further maturation of the neotissue,

93 Nude mice reconstituted with 10(5) T cells prior to chal

94 ansplantation of hERG1-expressing cells into nude mice resulted in an increased incidence of tumors.

95 5alpha-depleted pancreatic cancer cells into nude mice resulted in markedly reduced tumorigenicity (P

96 KD SCC1 cells into the floor of the mouth in nude mice resulted in the formation of significantly sma

97 ne was sufficient to induce tumorigenesis in nude mice resulting in short lifespan irrespective of wh

98 D25(+)IL7Ralpha(+)) after grafting recipient nude mice revealed that MPP3 cells were the most effecti

99 ografts of MKN45/5FU cells in the stomach of nude mice revealed that these cells had a high potential

100 SCs transplanted to the ischemic hindlimb of nude mice showed significantly higher BLI and PET signal

101 nt lymphocytes in the demyelinated lesion of nude mice spinal cord.

102 pressed DNAJB6a formed tumors more slowly in nude mice than control cells or cells that expressed a m

103 In 4T1 tumor-bearing nude mice that received intratumoral or intravenous inje

104 In contrast, nude mice that received T cells and 7-day treatment with

105 Diabetic athymic nude mice transplanted with 1500 to 3000 islet equivalen

106 Finally, PC3 xenograft nude mice treated with NLS in vivo showed a significant

107 lung cancer cells was found in zebrafish and nude mice tumor models.

108 hotopically implanted into other male BALB/c nude mice using microsurgical techniques.

109 ia conditions, were then assessed in healthy nude mice using the left kidney and spleen as reference

110 and direct intratibial injection of athymic nude mice was determined.

111 Growth of PLC5 tumor xenografts in BALB/c nude mice was inhibited by daily oral treatment with nil

112 of WT HBx-expressing cells to form tumors in nude mice was significantly higher than that of mutant H

113 ssing SKOV-3 ovarian carcinoma xenografts in nude mice was studied for a dosimetry assessment.

114 transplantation of 100 transduced cells into nude mice was sufficient for tumor formation.

115 Female BALB/c nude mice were injected intravenously with 0.064-42 kBq

116 When nude mice were maintained on a diet lacking geranylgeran

117 Nude mice were not protected by ST-246 alone or by 10 mi

118 and preliminary in vivo xenograft studies in nude mice were performed to evaluate target binding.

119 -fragment dose for imaging was determined in nude mice with a subcutaneous head and neck carcinoma mo

120 Treatment of nude mice with aminooxyacetic acid attenuated the growth

121 avenously administered every 3 d for 16 d to nude mice with AR42J tumor xenografts that were approxim

122 OIS and enabled tumor transplants to grow in nude mice with characteristic cell morphology of anaplas

123 In vivo treatment of A375 xenograft-bearing nude mice with cryptolepine (10 mg/Kg body weight, i.p.)

124 t overexpress MFSD2A were transferred to CD1 nude mice with dextran sodium sulfate-induced colitis, w

125 In tissue recombination studies in nude mice with immortalized prostatic epithelial cells e

126 Pretreatment of nude mice with oral ginsenoside Ro followed by HT29 intr

127 uorescence imaging to detect ccRCC tumors in nude mice with RCC xenografts by using mAb girentuximab

128 In vitro and in vivo studies (nude mice with SKOV-3 xenografts) showed that (i) drug (

129 ing product, (18)F-FVIIai, was injected into nude mice with subcutaneous human pancreatic xenograft t

130 11B6 uptake was performed on NMRI and BALB/c nude mice with subcutaneous LNCaP xenografts up to 14 d

131 ouse) was injected intravenously into BALB/c nude mice with subcutaneous PSMA-expressing LNCaP tumors

132 111)In-labeled ADCs were performed on BALB/c nude mice with subcutaneous PSMA-positive LS174T-PSMA xe

133 Two groups of 6 adult female BALB/c nude mice with subcutaneously implanted tumors underwent

134 Methods: Two groups of 6 adult female BALB/c nude mice with subcutaneously implanted tumors underwent

135 ary tumors, in an NFATc1-dependent manner in nude mice with T-cell deficiency, revealing an addiction

136 targeting potential and antitumor effects in nude mice with tumors that were sensitive or resistant t

137 d cell death and repressed tumor growth in a nude mice xenograft model (p < 0.05).

138 Importantly, an in vivo BALB/c nude mice xenograft model and tail vein injection model

139 -amplified neuroblastoma cells as well as in nude mice xenografted IMR32 cells.

140 ble for small-animal PET studies in multiple nude mice xenografted with the A431 carcinoma cell line.

141 Nude mice xenografted with the human NET cell line GOT1

142 Nude mice xenografts of HCC-70 or MDA-MB-468 were treate

143 nduced death in HT-29 and SW480 cells and in nude mice xenografts.

144 family mutation efficiently form sarcomas in nude mice, and a Ras-ZEB1-Akt pathway then causes transi

145 ces hypoxia in FaDu and HCT116 xenografts in nude mice, and causes a significant tumour growth delay

146 lorectal cancer metastases were generated in nude mice, and epifluorescence imaging of ICG, as well a

147 and H1975) were subcutaneously implanted in nude mice, and growth was followed by caliper measuremen

148 ry tumorigenesis in tumor cell allografts in nude mice, and in MMTV-Neu transgenic mice.

149 matrix proteins, subcutaneous tumor size in nude mice, and invasive behavior, including bone marrow

150 nd cervical cancer cell xenograft in vivo in nude mice, and suppress cervical cancer cell migration a

151 nt growth inhibition of MOLM13 xenografts in nude mice, and the activity correlates with inhibition o

152 bodies and transferred into infected SCID or nude mice, and the animals received the same antibody ev

153 2 were injected into the pancreas of athymic nude mice, and their local and distant spread was monito

154 molecules were then determined in naive CD-1 nude mice, and tumor targeting was assessed in CD-1 nude

155 ously and orthotopically implanted tumors in nude mice, and was accompanied by c-SRC downregulation.

156 Within window chambers in nude mice, cardiopatches undergo vascularization by host

157 nhibited orthotopic prostate tumor growth in nude mice, compared with monotherapy, by reversing the e

158 taneously injected into CD-1 nude mice (CD-1 nude mice, Crl:CD1-Foxn1(nu); Charles River Laboratories

159 Importantly, when engrafted into nude mice, decitabine(R) and PKC412(R) had faster prolif

160 cells were subcutaneously transplanted into nude mice, DPSC/CTL cells induced mineralized tissue for

161 Remarkably, when transplanted onto nude mice, engrafted SRF-null skin lacked hair but displ

162 utside the primary tumor microenvironment in nude mice, exhibited signatures of immune evasion, incre

163 Moreover, in MDA-MB-231-bearing nude mice, H3L2 induced dysfunctional angiogenesis and t

164 uding HUVEC-mediated trophoblast invasion in nude mice, in vitro three-dimensional capillary tube for

165 tants strongly decreased tumor metastases in nude mice, indicating the requirement of PTTG for STAT3-

166 rs and xenografts established in NOD-SCID or nude mice, low MCPIP1 levels correlated strongly with in

167 the growth of GBM tumors, transplanted into nude mice, more than DOX alone.

168 uman prostate xenograft model established in nude mice, RAD001 alone or in combination with docetaxel

169 lonization of melanoma cells in the lungs of nude mice, suggesting an increase in metastatic potentia

170 Despite previous passage on nude mice, the expression of epithelial, stromal and imm

171 expressing versican siRNA were injected into nude mice, the resulting tumors displayed significantly

172 n PMP tissue was i.p. grafted and grown into nude mice, then constituted into reliable and reproducib

173 and AGS, which do and do not form tumors in nude mice, to identify their genomic differences relevan

174 an ovarian SKOV3 tumors cells into 14 female nude mice, treatment with vehicle or pazopanib (2.5 mg p

175 e than WT cybrids, however, when injected in nude mice, tRNAmut cybrids produced larger tumours and s

176 sing head and neck cancer xenograft model in nude mice, tumor growth was inhibited by CXCR7-targeting

177 on in PCa cells and induces larger tumors in nude mice, whereas its silencing decreased proliferation

178 sulted in marked regression of xenografts in nude mice, whereas the delivery of an miR-125a inhibitor

179 g in aggressive tumor formation in xenograft nude mice, which could be suppressed by combined treatme

180 Chronic treatment of nude mice, which had been inoculated with MDA-MB-231 cel

181 ive in suppressing xenograft tumor growth in nude mice, which underlines the translational potential

182 ous cell carcinoma upon inoculation into the nude mice, while parental HaCaT cells remain non-tumorig

183 ctionally less effective at wound closure in nude mice.

184 l migration and abolished lung metastasis in nude mice.

185 bits proteasome function and tumor growth in nude mice.

186 cycle analysis and in vivo tumorigenesis in nude mice.

187 -expressing human lung cancer cell line into nude mice.

188 he multidrug resistant MCF-7/ADR xenografted nude mice.

189 plates, colonies in soft agar, and tumors in nude mice.

190 ses tumor growth and metastatic potential in nude mice.

191 rived orthotopic xenograft tumors in athymic nude mice.

192 istant human ovarian cancer cells in athymic nude mice.

193 ts and increases the median survival time of nude mice.

194 ancer cell proliferation and tumor growth in nude mice.

195 dard in vivo ectopic osteoinduction assay in nude mice.

196 on and a matrigel plug angiogenesis assay in nude mice.

197 blot assays, or injected subcutaneously into nude mice.

198 bited their tumorigenicity when engrafted in nude mice.

199 Calif) and injected in both flanks of eight nude mice.

200 a A375 human melanoma tumor model in athymic nude mice.

201 ion of breast cancer cell line xenografts in nude mice.

202 tocin-induced 8- to 10-week-old male athymic nude mice.

203 doses of a (90)Y-labeled GRPr antagonist in nude mice.

204 ess differentiated tumors when injected into nude mice.

205 d into the distal posterior rectum of BALB/c-nude mice.

206 cell line and in vivo in PC-3 tumor-bearing nude mice.

207 nospheres in soft agar and nodules/tumors in nude mice.

208 gnificantly suppressed by NOS2 inhibition in nude mice.

209 in culture and promotes xenograft growth in nude mice.

210 duced tumorigenesis in an allograft model of nude mice.

211 ther subcutaneously or intraperitoneally, in nude mice.

212 ells in vitro and induces tumor formation in nude mice.

213 tion with the capacity to form metastases in nude mice.

214 orsphere assays and were less tumorigenic in nude mice.

215 sitive neovasculature when transplanted into nude mice.

216 man pancreatic adenocarcinomas propagated in nude mice.

217 and orthotopic xenografts of CL1-5 cells in nude mice.

218 rongly reduced the growth of ccRCC tumors in nude mice.

219 to enhanced lethality of tumor xenografts in nude mice.

220 tides targeting HE4 arrested tumor growth in nude mice.

221 d enhanced metastatic potential in allograft-nude mice.

222 nd diminishes tumorigenesis of xenografts in nude mice.

223 eration in vitro and HCC xenograft growth in nude mice.

224 lations markedly inhibited tumorigenicity in nude mice.

225 proliferation, migration and tumor growth in nude mice.

226 oliferation in vitro and after grafting onto nude mice.

227 the AKT pathway in the CAM model, as well as nude mice.

228 cells that were subcutaneously implanted in nude mice.

229 n promotes tumor growth of AFP- HCC cells in nude mice.

230 nospheres in soft agar and nodules/tumors in nude mice.

231 1 in vitro but also enhanced tumor growth in nude mice.

232 nograft growth and invasion of CRC tumors in nude mice.

233 gar, and increased xenograft tumor growth in nude mice.

234 s and generated transplantable xenografts in nude mice.

235 rived xenografts expressing SLC13A5-shRNA in nude mice.

236 ream of EN, and abolishes tumor formation in nude mice.

237 ration and tumor formation and metastasis in nude mice.

238 reased growth of tumor xenografts in athymic nude mice.

239 inhibition of HCC xenograft tumor growth in nude mice.

240 -amplified neuroblastoma xenograft growth in nude mice.

241 the human osteosarcoma MNNG/HOS xenograft in nude mice.

242 rowth inhibition of LoVo xenografts grown in nude mice.

243 t growth in 3T3 cells and tumor formation in nude mice.

244 of mammospheres and reduced tumor volume in nude mice.

245 ed the growth of human leukemia xenograft in nude mice.

246 th of xenograft tumors from HCT-116 cells in nude mice.

247 elial MCF-10A cells with malignant growth in nude mice.

248 culture, and tumor growth and metastasis in nude mice.

249 osis, and marked regression of xenografts in nude mice.

250 skin on the muzzles and tails of athymic NCr nude mice.

251 colorectal xenograft tumors was examined in nude mice.

252 nvasion, migration, and xenograft tumors, in nude mice.

253 KB-3-1 and COLO-205 tumor xenograft-bearing nude mice.

254 xenografts in the mammary fat pads of female nude mice.

255 to be nearly abolished in immunocompromised nude mice.

256 llomavirus has shown broad tissue tropism in nude mice.

257 CSC-like cells formed subcutaneous tumors in nude mice.

258 nd promotes the formation of fibrosarcoma in nude mice.

259 on and peritoneal tumor formation in athymic nude mice.

260 cells (A2780) implanted orthotopically into nude mice.

261 lation, Ki-67 expression and tumor growth in nude mice.

262 s ATF4 expression and its tumor formation on nude mice.

263 HV (TIVE-KSHV) into hyperglycemic and normal nude mice.

264 ly into NTR1-positive HT29 xenograft-bearing nude mice.

265 anted into calvarial defects created in CD-1 nude mice.

266 inhibition of HCC xenograft tumor growth in nude mice.

267 ggressive orthotopic tumor models in athymic nude mice: a human PC-3 M-luc-C6 prostate tumor and a hu

268 Nude mouse bioassay demonstrated better islet function f

269 nsional culture and in an in vivo orthotopic nude mouse model of HNSCC through a novel transcription-

270 l lines and a spleen subcapsular inoculation nude mouse model were also used.

271 In the NMRI nude mouse model, we observed up to a 4.5-fold increase

272 elayed MPNST formation in an MPNST xenograft nude mouse model.

273 cancer cells in 4T1.2 BALB/cJ and MDA-MB-231 nude mouse models.

274 All athymic nude mouse strains showed active infections at both cuta

275 y, these in vitro results were replicated in nude mouse transplanted tumor models.

276 ion and a marked decrease in tumor growth in nude mouse xenograft assays.

277 regulation on tumor growth was analyzed in a nude mouse xenograft model.

278 itory activity against human glioblastoma in nude mouse xenograft models.

279 Growth suppression of nude mouse xenograft tumors carrying a tetracycline-indu

280 ly examined MMP-2 in live cells and tumor on nude mouse, respectively.

281 h of xenografted cervical tumor implanted in nude mouse.

282 nesis upon subcutaneous transplantation in a nude mouse.

283 resent study, we generated a novel strain of nude NOD/SCID/IL2rg(-/-) (NSIN) mice by knocking out Fox

284 was studied in normal and immune-deficient (nude, nu/nu) BALB/c mice infected with vaccinia virus (V

285 t but not in immunodeficient (IFNgamma(-/-), nude, or CD8(-/-)) mice.

286 The Khc73 stalk/14-3-3/NudE pathway defines a physical connection that coordina

287 premalignancy and (b) an in vivo orthotopic nude rat lung cancer model to evaluate response to epige

288 efficacy of the DOT1L inhibitor EPZ5676 in a nude rat xenograft model of DNMT3A-mutant AML.

289 In vivo conditioning in nude rats did not confer TLR4 expression in hESC-EC.

290 or 13 d and then implanted subcutaneously in nude rats for 4 and 8 wk.

291 Twenty-three nude rats underwent successful left anterior descending

292 eck and 10 HT29 colorectal carcinoma-bearing nude rats were studied.

293 Male nude rats were subcutaneously inoculated in the shoulder

294 To study this, we inoculated 30 nude rats with HER2-positive cells derived from a brain

295 ved grafting into the spinal cord of athymic nude rats with no signs of overgrowth and with a very si

296 bcutaneous cancer esophageal xenografts, and nude rats with orthotopic esophageal cancers in four stu

297 lop into NK cells, but DKO BM transfers into nude recipients and NK cells in E4BP4/Rag-1/IL-7 triple-

298 cell immune system since it did not occur in nude, severe combined immunodeficiency, or T-cell deplet

299 epsilon heterodimer binds the Dynein adaptor NudE to complete the Dynein connection.

300 Transfer of T cells from transplanted nudes to syngeneic black-coated RAG(-/-) recipients caus